Obesity and male breast cancer: provocative parallels?

被引:26
|
作者
Humphries, Matthew P. [1 ]
Jordan, V. Craig [2 ]
Speirs, Valerie [1 ]
机构
[1] Univ Leeds, St Jamess Univ Hosp, Leeds Inst Canc & Pathol, Leeds LS9 7TF, W Yorkshire, England
[2] Univ Texas Houston, MD Anderson Canc Ctr, Dept Breast Med Oncol & Mol & Cellular Oncol, Houston, TX 77030 USA
来源
BMC MEDICINE | 2015年 / 13卷
关键词
Aromatase; Aromatase inhibitor; Body mass index; Estrogen; Incidence; Male breast cancer; Obesity; Risk factor; Selective estrogen receptor modulator; Tamoxifen; BODY-MASS INDEX; ADIPOSE-TISSUE; HYPOGONADOTROPIC HYPOGONADISM; GONADOTROPIN-SECRETION; AROMATASE INHIBITORS; POSTMENOPAUSAL WOMEN; SEX-HORMONES; RISK-FACTORS; MEN; ESTROGEN;
D O I
10.1186/s12916-015-0380-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
While rare compared to female breast cancer the incidence of male breast cancer (MBC) has increased in the last few decades. Without comprehensive epidemiological studies, the explanation for the increased incidence of MBC can only be speculated. Nevertheless, one of the most worrying global public health issues is the exponential rise in the number of overweight and obese people, especially in the developed world. Although obesity is not considered an established risk factor for MBC, studies have shown increased incidence among obese individuals. With this observation in mind, this article highlights the correlation between the increased incidence of MBC and the current trends in obesity as a growing problem in the 21st century, including how this may impact treatment. With MBC becoming more prominent we put forward the notion that, not only is obesity a risk factor for MBC, but that increasing obesity trends are a contributing factor to its increased incidence.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Obesity, insulin resistance and breast cancer outcomes
    Goodwin, Pamela J.
    BREAST, 2015, 24 : S56 - S59
  • [22] Contemporary Systemic Therapy for Male Breast Cancer
    Bradley, Katherine L.
    Tyldesley, Scott
    Speers, Caroline H.
    Woods, Ryan
    Villa, Diego
    CLINICAL BREAST CANCER, 2014, 14 (01) : 31 - 39
  • [23] Collaborative modeling of the impact of obesity on race-specific breast cancer incidence and mortality
    Chang, Yaojen
    Schechter, Clyde B.
    van Ravesteyn, Nicolien T.
    Near, Aimee M.
    Heijnsdijk, Eveline A. M.
    Adams-Campbell, Lucile
    Levy, David
    de Koning, Harry J.
    Mandelblatt, Jeanne S.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 136 (03) : 823 - 835
  • [24] The Impact of Obesity on Breast Cancer
    Argolo, Daniel F.
    Hudis, Clifford A.
    Iyengar, Neil M.
    CURRENT ONCOLOGY REPORTS, 2018, 20 (06)
  • [25] Ghrelin and Breast Cancer: emerging Roles in Obesity, estrogen Regulation, and Cancer
    Au, CheukMan Cherie
    Furness, John B.
    Brown, Kristy A.
    FRONTIERS IN ONCOLOGY, 2017, 6
  • [26] Obesity and Breast Cancer: A Case of Inflamed Adipose Tissue
    Kolb, Ryan
    Zhang, Weizhou
    CANCERS, 2020, 12 (06) : 1 - 18
  • [27] Obesity and Breast Cancer: Interaction or Interference with the Response to Therapy?
    Riondino, Silvia
    Formica, Vincenzo
    Valenzi, Elena
    Morelli, Cristina
    Flaminio, Valeria
    Portarena, Ilaria
    Torino, Francesco
    Roselli, Mario
    CURRENT ONCOLOGY, 2023, 30 (01) : 1220 - 1231
  • [28] Adolescent obesity and adult male breast cancer in a cohort of 1,382,093 men
    Keinan-Boker, Lital
    Levine, Hagai
    Leiba, Adi
    Derazne, Estela
    Kark, Jeremy D.
    INTERNATIONAL JOURNAL OF CANCER, 2018, 142 (05) : 910 - 918
  • [29] The Role of Obesity in the Etiology and Carcinogenesis of Endometrial Cancer
    Marin, Alina-Gabriela
    Filipescu, Alexandru
    Petca, Aida
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [30] Male Breast Cancer: a Review on Diagnosis, Treatment, and Survivorship
    Bhardwaj, Prarthna, V
    Gupta, Shilpi
    Elyash, Alexa
    Teplinsky, Eleonora
    CURRENT ONCOLOGY REPORTS, 2024, 26 (01) : 34 - 45